258 related articles for article (PubMed ID: 153705)
1. Experimental transplantation and histocompatibility systems in the canine species.
Rapaport FT; Bachvaroff RJ
Adv Vet Sci Comp Med; 1978; 22():195-219. PubMed ID: 153705
[No Abstract] [Full Text] [Related]
2. Histocompatibility testing in clinical renal transplantation.
Braun WE
Urol Clin North Am; 1983 May; 10(2):231-42. PubMed ID: 6222529
[No Abstract] [Full Text] [Related]
3. The HLA system in human pathology.
Suciu-Foca N
Pathobiol Annu; 1979; 9():81-111. PubMed ID: 113764
[No Abstract] [Full Text] [Related]
4. Failure of antithymocyte serum postgrafting to overcome "resistance" to DLA-nonidentical canine marrow grafts.
Storb R; Raff RF; Appelbaum FR; Schuening F; Sandmaier B; Shulman H; Deeg HJ; Graham T
Transplantation; 1988 Jan; 45(1):236-9. PubMed ID: 3276053
[No Abstract] [Full Text] [Related]
5. Mechanisms of prolongation of graft survival.
Carpenter CB
Transplant Proc; 1979 Dec; 11(4):1885-8. PubMed ID: 161100
[No Abstract] [Full Text] [Related]
6. Bone marrow transplanation for severe combined immunodeficiency with the HL-A-incompatible but MLC-identical mother as a donor.
Neithammer D; Goldmann SF; Haas RJ; Dietrich M; Flad HD; Fliedner TM; Kleihauer E
Transplant Proc; 1976 Dec; 8(4):623-8. PubMed ID: 11594
[No Abstract] [Full Text] [Related]
7. HLA-D antigen disparity and HLA-DRw antibodies in intrafamilial renal allograft survival.
Cochrum K; Hanes D; Van Speybroeck J; Perkins H; Ferrone S; Indeveri F; Amend W; Vincenti F; Feduska N; Salvatierra O
Transplant Proc; 1979 Mar; 11(1):404-10. PubMed ID: 156426
[No Abstract] [Full Text] [Related]
8. Experimental skin grafting in man.
Jonker M; Hoogeboom J; van Leeuwen A; Koch C; van Oud Alblas DB; Persijn G; Frederiks E; van Rood J
Transplant Proc; 1979 Mar; 11(1):607-10. PubMed ID: 156429
[No Abstract] [Full Text] [Related]
9. Differential effects of horse ATG and rabbit ATG on T cell and T cell subset levels measured by monoclonal antibodies.
Thomas FT; Griesedieck C; Thomas J; Carver M; Whitley T; Warren R; Williams D
Transplant Proc; 1984 Dec; 16(6):1561-3. PubMed ID: 6239426
[No Abstract] [Full Text] [Related]
10. Circulating antibodies in allograft recipients.
Revillard JP; Betuel H
Adv Nephrol Necker Hosp; 1975; 5():257-81. PubMed ID: 127522
[No Abstract] [Full Text] [Related]
11. Failure of engraftment and graft-versus-host disease after canine marrow transplantation. Two phenomena linked to but not exclusively determined by known antigens of the major histocompatibility complex.
Storb R; Weiden PL; Graham TC; Thomas ED
Transplant Proc; 1978 Mar; 10(1):113-8. PubMed ID: 24904
[No Abstract] [Full Text] [Related]
12. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
[TBL] [Abstract][Full Text] [Related]
13. Engraftment of allogeneic dog bone marrow.
Vriesendorp HM; Zurcher C; van Bekkum DW
Transplant Proc; 1975 Dec; 7(4):465-8. PubMed ID: 825
[TBL] [Abstract][Full Text] [Related]
14. Exceptionally long survival time in xenogeneic organ transplantation.
Hammer C; Chaussy C; Welter H; Wembacher J; Höbel G; Brendel W
Transplant Proc; 1981 Mar; 13(1 Pt 2):881-4. PubMed ID: 6455827
[No Abstract] [Full Text] [Related]
15. Analysis of the major histocompatibility complex in Syrian hamsters. I. Skin graft rejection, graft-versus-host reactions, mixed lymphocyte reactions, and immune response genes in inbred strains.
Duncan WR; Streilein JW
Transplantation; 1978 Jan; 25(1):12-16. PubMed ID: 22947
[TBL] [Abstract][Full Text] [Related]
16. Enhanced survival of canine renal allografts of ALS- treated dogs given bone marrow.
Caridis DT; Liegeois A; Barrett I; Monaco AP
Transplant Proc; 1973 Mar; 5(1):671-4. PubMed ID: 4572126
[No Abstract] [Full Text] [Related]
17. Progress in the prevention of GVH: bone marrow grafts after ALG conditioning, with lymphocyte split chimerism, use of a lymphocyte "chalone T", and soluble histocompatibility antigens.
Mathé G; Kiger N; Florentin I; Garcia-Giralt E; Martyre MC; Halle-Pannenko O; Schwartzenberg L
Transplant Proc; 1973 Mar; 5(1):933-9. PubMed ID: 4144474
[No Abstract] [Full Text] [Related]
18. Preexistent anti-HLA-DR antibodies and kidney graft survival.
Sirchia G; Mercuriali F; Scalamogna M; Rosso di San Secondo V; Pizzi C; Poli F; Fortis C; Greppi N
Transplant Proc; 1979 Mar; 11(1):950-3. PubMed ID: 377727
[No Abstract] [Full Text] [Related]
19. The role of HLA class II antigens/genes in xenogeneic iso, allo, and xeno transplantation.
Tsuji K; Hagihara M; Sato T; Shimura T; Takebe K; Munkhbat B
Transplant Proc; 1994 Aug; 26(4):2441-3. PubMed ID: 8066801
[No Abstract] [Full Text] [Related]
20. [HLA-compatibility testing in kidney transplantation--past, present and future].
van Rood JJ; Persijn GG; van Leeuwen A; Goulmy E; Lansbergen Q; Cohen B
Chirurg; 1980 May; 51(5):257-62. PubMed ID: 6447582
[No Abstract] [Full Text] [Related]
[Next] [New Search]
